US 12281111
Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same
granted A61KA61K31/437A61K31/4545
Quick answer
US patent 12281111 (Substituted pyrrolopyridine JAK inhibitors and methods of making and using the same) held by Aclaris Therapeutics, Inc. expires Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Aclaris Therapeutics, Inc.
- Grant date
- Tue Apr 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K31/437, A61K31/4545, A61K45/06, A61P